BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27457475)

  • 1. Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small cell lung cancer after EGFR tyrosine kinase inhibitor treatment.
    Izumo T; Matsumoto Y; Chavez C; Tsuchida T
    BMC Pulm Med; 2016 Jul; 16(1):106. PubMed ID: 27457475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endobronchial ultrasound-guided re-biopsy of non-small cell lung cancer with acquired resistance after EGFR tyrosine kinase inhibitor treatment.
    Hong KS; Cho J; Jang JG; Jang MH; Ahn JH
    Thorac Cancer; 2023 Feb; 14(4):363-370. PubMed ID: 36525475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoscopic Re-biopsy for Mutational Analysis of Non-small Cell Lung Cancer.
    Kirita K; Izumo T; Matsumoto Y; Hiraishi Y; Tsuchida T
    Lung; 2016 Jun; 194(3):371-8. PubMed ID: 26951235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.
    Esterbrook G; Anathhanam S; Plant PK
    Lung Cancer; 2013 Apr; 80(1):30-4. PubMed ID: 23312886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of epidermal growth factor receptor mutation by endobronchial ultrasound-guided transbronchial needle aspiration.
    Nakajima T; Yasufuku K; Suzuki M; Hiroshima K; Kubo R; Mohammed S; Miyagi Y; Matsukuma S; Sekine Y; Fujisawa T
    Chest; 2007 Aug; 132(2):597-602. PubMed ID: 17573511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).
    Reynolds JP; Tubbs RR; Minca EC; MacNamara S; Almeida FA; Ma PC; Pennell NA; Cicenia JC
    Lung Cancer; 2014 Nov; 86(2):158-63. PubMed ID: 25263855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of transbronchial needle aspiration with endobronchial ultrasonography using a guide sheath for peripheral pulmonary lesions suspected to be lung cancer.
    Arimura K; Sekine Y; Hiroshima K; Sato A; Hasegawa M; Katsura H; Tagaya E; Kondo M; Tamaoki J
    Respir Investig; 2017 Nov; 55(6):365-371. PubMed ID: 29153417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration.
    Nakajima T; Yasufuku K; Nakagawara A; Kimura H; Yoshino I
    Chest; 2011 Nov; 140(5):1319-1324. PubMed ID: 21527506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rebiopsy methods and clinical features on T790M mutation after first-line EGFR-TKI treatment failure.
    Zhou J; Li Y; Zhang Y; Dai H; Guo S
    Future Oncol; 2021 Jul; 17(19):2475-2488. PubMed ID: 33769072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients.
    Navani N; Brown JM; Nankivell M; Woolhouse I; Harrison RN; Jeebun V; Munavvar M; Ng BJ; Rassl DM; Falzon M; Kocjan G; Rintoul RC; Nicholson AG; Janes SM
    Am J Respir Crit Care Med; 2012 Jun; 185(12):1316-22. PubMed ID: 22505743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies.
    Uozu S; Imaizumi K; Yamaguchi T; Goto Y; Kawada K; Minezawa T; Okamura T; Akao K; Hayashi M; Isogai S; Okazawa M; Hashimoto N; Hasegawa Y
    BMC Pulm Med; 2017 Dec; 17(1):175. PubMed ID: 29212495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adequacy of EBUS-TBNA specimen for mutation analysis of lung cancer.
    Cicek T; Ozturk A; Yılmaz A; Aktas Z; Demirag F; Akyurek N
    Clin Respir J; 2019 Feb; 13(2):92-97. PubMed ID: 30582673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic ultrasound-guided fine needle aspiration and endobronchial ultrasound-guided transbronchial needle aspiration: Are two better than one in mediastinal staging of non-small cell lung cancer?
    Oki M; Saka H; Ando M; Kitagawa C; Kogure Y; Seki Y
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1169-77. PubMed ID: 24930616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients.
    Ko R; Kenmotsu H; Serizawa M; Koh Y; Wakuda K; Ono A; Taira T; Naito T; Murakami H; Isaka M; Endo M; Nakajima T; Ohde Y; Yamamoto N; Takahashi K; Takahashi T
    BMC Cancer; 2016 Nov; 16(1):864. PubMed ID: 27821131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients.
    Kuiper JL; Heideman DA; Thunnissen E; Paul MA; van Wijk AW; Postmus PE; Smit EF
    Lung Cancer; 2014 Jul; 85(1):19-24. PubMed ID: 24768581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle Aspiration.
    Casadio C; Guarize J; Donghi S; Di Tonno C; Fumagalli C; Vacirca D; Dell'Orto P; De Marinis F; Spaggiari L; Viale G; Barberis M
    Am J Clin Pathol; 2015 Oct; 144(4):629-34. PubMed ID: 26386084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Programmed Death Ligand-1 Immunohistochemical Staining Between Endobronchial Ultrasound Transbronchial Needle Aspiration and Resected Lung Cancer Specimens.
    Sakata KK; Midthun DE; Mullon JJ; Kern RM; Nelson DR; Edell ES; Schiavo DN; Jett JR; Aubry MC
    Chest; 2018 Oct; 154(4):827-837. PubMed ID: 30059678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer.
    Kim J; Kang HJ; Moon SH; Lee JM; Kim HY; Lee GK; Lee JS; Hwangbo B
    Cancer Res Treat; 2019 Oct; 51(4):1488-1499. PubMed ID: 30913867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed?
    Yarmus L; Akulian J; Gilbert C; Feller-Kopman D; Lee HJ; Zarogoulidis P; Lechtzin N; Ali SZ; Sathiyamoorthy V
    Ann Am Thorac Soc; 2013 Dec; 10(6):636-43. PubMed ID: 24079724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBUS-TBNA provides highest RNA yield for multiple biomarker testing from routinely obtained small biopsies in non-small cell lung cancer patients - a comparative study of three different minimal invasive sampling methods.
    Schmid-Bindert G; Wang Y; Jiang H; Sun H; Henzler T; Wang H; Pilz LR; Ren S; Zhou C
    PLoS One; 2013; 8(10):e77948. PubMed ID: 24205040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.